Page last updated: 2024-10-25

clioquinol and Idiopathic Pulmonary Fibrosis

clioquinol has been researched along with Idiopathic Pulmonary Fibrosis in 1 studies

Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.

Idiopathic Pulmonary Fibrosis: A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhu, Y1
Chang, J1
Tan, K1
Huang, SK1
Liu, X1
Wang, X1
Cao, M1
Zhang, H1
Li, S1
Duan, X1
Chang, Y1
Fan, Y1
Cao, P1

Other Studies

1 other study available for clioquinol and Idiopathic Pulmonary Fibrosis

ArticleYear
Clioquinol Attenuates Pulmonary Fibrosis through Inactivation of Fibroblasts via Iron Chelation.
    American journal of respiratory cell and molecular biology, 2021, Volume: 65, Issue:2

    Topics: Animals; Bleomycin; Chelating Agents; Clioquinol; Disease Models, Animal; Female; Fibroblasts; Human

2021